检索历史清除

首页> bioRxiv : the preprint server for biology> Advancing Clinical Response Against Glioblastoma: Evaluating SHP1705 CRY2 Activator Efficacy in Preclinical Models and Safety in Phase I Trials.

Advancing Clinical Response Against Glioblastoma: Evaluating SHP1705 CRY2 Activator Efficacy in Preclinical Models and Safety in Phase I Trials.

导出 LinkOut

翻译打印收藏纠错

第一作者： Priscilla,Chan

作者： Priscilla,Chan ; Yoshiko,Nagai ; Qiulian,Wu ; Anahit,Hovsepyan ; Seda,Mkhitaryan ; Jiarui,Wang ; Gevorg,Karapetyan ; Theodore,Kamenecka ; Laura A,Solt ; Jamie,Cope ; Rex A,Moats ; Tsuyoshi,Hirota ; Jeremy N,Rich ; Steve A,Kay

DOI 10.1101/2024.09.17.613520

PMID 39345648

发布时间 2024-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交